Overall survival benefit from surgical resection in treatment of recurrent glioblastoma.
作者信息
Mann B S
机构信息
Adult Brain and GU Cancers Therapeutics, Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, USA.
出版信息
Ann Oncol. 2014 Sep;25(9):1866-1867. doi: 10.1093/annonc/mdu243. Epub 2014 Jul 10.
Abstract
摘要
相似文献
1
Overall survival benefit from surgical resection in treatment of recurrent glioblastoma.手术切除治疗复发性胶质母细胞瘤的总体生存获益。
Ann Oncol. 2014 Sep;25(9):1866-1867. doi: 10.1093/annonc/mdu243. Epub 2014 Jul 10.
2
Editorial: glioblastoma and surgery.社论：胶质母细胞瘤与手术
J Neurosurg. 2013 Apr;118(4):809-11; discussion 810-1. doi: 10.3171/2012.5.JNS12690. Epub 2012 Oct 19.
3
Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.复发胶质母细胞瘤切除术范围对总生存期的影响：临床文章。
J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.
4
Surgery, a prognostic marker for progression-free survival?手术，无进展生存期的一个预后标志物？
Neuro Oncol. 2012 Apr;14(4):390-1; author reply 391. doi: 10.1093/neuonc/nos057.
5
Resection of recurrent glioblastoma multiforme in elderly patients: a pseudo-randomized analysis revealed clinical benefit.老年复发性多形性胶质母细胞瘤切除术：一项伪随机分析显示出临床获益。
J Neurooncol. 2020 Jan;146(2):381-387. doi: 10.1007/s11060-020-03393-z. Epub 2020 Jan 13.
6
An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.复发性胶质母细胞瘤的切除程度及其对神经发病率的风险。
J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.
7
Reoperation for Recurrent Glioblastoma Multiforme.复发性多形性胶质母细胞瘤的再次手术
Neurosurg Clin N Am. 2017 Jul;28(3):407-428. doi: 10.1016/j.nec.2017.02.007.
8
Multiple resections for patients with glioblastoma: prolonging survival.多次切除手术治疗胶质母细胞瘤患者：延长生存期。
J Neurosurg. 2013 Apr;118(4):812-20. doi: 10.3171/2012.9.JNS1277. Epub 2012 Oct 19.
9
Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.针对局灶性复发性原发性胶质母细胞瘤的积极重复手术：结果与理论框架
Neurosurg Focus. 2015 Mar;38(3):E11. doi: 10.3171/2014.12.FOCUS14726.
10
Benefit of tumor resection for recurrent glioblastoma.复发性胶质母细胞瘤肿瘤切除的益处。
J Neurooncol. 2014 Apr;117(2):365-72. doi: 10.1007/s11060-014-1397-2. Epub 2014 Feb 15.
引用本文的文献
1
Patient-derived glioblastoma stem cells respond differentially to targeted therapies.患者来源的胶质母细胞瘤干细胞对靶向治疗反应不同。
Oncotarget. 2016 Dec 27;7(52):86406-86419. doi: 10.18632/oncotarget.13415.
2
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.在再次放疗背景下对复发性高级别胶质瘤进行再次切除：并非切除范围越大越好。
J Neurooncol. 2015 Sep;124(2):215-21. doi: 10.1007/s11060-015-1825-y. Epub 2015 May 30.
本文引用的文献
1
Benefit of tumor resection for recurrent glioblastoma.复发性胶质母细胞瘤肿瘤切除的益处。
J Neurooncol. 2014 Apr;117(2):365-72. doi: 10.1007/s11060-014-1397-2. Epub 2014 Feb 15.
2
An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.复发性胶质母细胞瘤的切除程度及其对神经发病率的风险。
J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.
3
Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.复发胶质母细胞瘤切除术范围对总生存期的影响：临床文章。
J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.
4
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.复发性胶质母细胞瘤患者预后预测的新预后因素和计算器：EORTC 脑肿瘤组 I 期和 II 期临床试验的汇总分析。
Eur J Cancer. 2012 May;48(8):1176-84. doi: 10.1016/j.ejca.2012.02.004. Epub 2012 Mar 28.
5
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?对于复发性胶质母细胞瘤患者，进展时手术是否是 6 个月无进展生存期或总生存期改善的预后标志物？
Neuro Oncol. 2011 Oct;13(10):1118-24. doi: 10.1093/neuonc/nor110. Epub 2011 Aug 2.
Zotero 插件